Mr. Thierry Dumas reports

OPSENS APPOINTS DENIS HARRINGTON TO ITS BOARD OF DIRECTORS

Opsens Inc. has appointed Denis Harrington as a director of the company.

Mr. Harrington owns a management and strategy consulting firm he founded in 2012. Prior to managing his own company, he worked for several medical companies and, among other things, led BridgePoint Medical, Inc., as chief executive officer, from the development stage through commercialization and to a successful acquisition by Boston Scientific Corp. in October, 2012. He joined Boston Scientific in 1993 and worked for it for 18 years in various roles of increasing responsibility in the U.S. sales organization. Some of his most impressive achievements included managing over 1,800 people and $3-billion (U.S.) in revenue as senior vice-president cardiology, rhythm and vascular sales. He also played an integral role in the launch of Boston Scientific's Taxus stent platform as senior vice-president cardiology sales -- driving unprecedented revenue growth for the corporation.

A graduate of the West Point United States Military Academy, he served for five years in the United States Army, attaining the rank of Captain. His service was focused in various leadership capacities including platoon and company leadership roles.

Opsens appoints chairman to the board of directors

Opsens has also appointed Denis M. Sirois as chairman of its board of directors. Mr. Sirois, vice-president, investments, at Telesystem Ltd., has been sitting on Opsens's board of directors since 2006.

Mr. Sirois, recently nominated as chairman of the board, declared: "The board of directors is pleased to welcome Denis Harrington. I want to extend my congratulations and wish him success in his term. His appointment will further enrich Opsens's level of expertise. "

We seek Safe Harbor.